OraSure Submits CT/NG Molecular Self-Test and Colli-Pee(TM) Urine Collection Device for FDA Review

Stock Information for Biote Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biote Corp.

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance
OraSure Announces Fourth Quarter 2025 Financial Results
OraSure to Launch OraQuick(TM) HIV Self-Test in Canada
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.